Earnings Call · Q3 FY2025·2025-10-28

Q3 25EPS +100.00%*·Rev n/aQ2 25EPS +18.75%·Rev n/aQ1 25EPS +4.76%·Rev n/aQ4 24EPS +65.95%·Rev n/a⚠ consensus missing

Arcutis Biotherapeutics, Inc. ARQT

Brian Scholkoff — Chief Executive Officer

Todd Watanabe — President and Chief Operating Officer

Todd Edwards — Chief Commercial Officer

Latha Vairavan — Chief Financial Officer

Patrick Burnett — Chief Medical Officer

+27.0%1d on move date+26.8% vs SPY3d+26.9%5d+26.1%

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ARQT calls or request research access.

More ARQT calls Browse calls Request research access